DENALI THERAPEUTICS IN
29.33
07-November-24 13:33:34
15 minutes delayed
Stocks
-0.22
-0.74%
Today's range
29.02 - 31.41
ISIN
N/A
Source
NASDAQ
-
25 Jan 2023 07:00:00 By Nasdaq GlobeNewswire
-
09 Jan 2023 07:00:44 By Nasdaq GlobeNewswire
-
05 Dec 2022 06:00:41 By Nasdaq GlobeNewswire
-
Denali Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
03 Nov 2022 15:01:44 By Nasdaq GlobeNewswire
-
01 Nov 2022 07:00:02 By Nasdaq GlobeNewswire
-
24 Oct 2022 15:30:04 By Nasdaq GlobeNewswire
-
Denali Therapeutics Announces Pricing of $275 Million Public Offering of Common Stock
19 Oct 2022 20:19:42 By Nasdaq GlobeNewswire
-
Denali Therapeutics Announces Proposed Offering of Common Stock
18 Oct 2022 15:40:50 By Nasdaq GlobeNewswire
-
03 Oct 2022 07:00:39 By Nasdaq GlobeNewswire
-
31 Aug 2022 07:00:01 By Nasdaq GlobeNewswire
-
Denali Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
08 Aug 2022 15:01:01 By Nasdaq GlobeNewswire
-
31 May 2022 07:00:02 By Nasdaq GlobeNewswire
-
Denali Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights
05 May 2022 15:01:01 By Nasdaq GlobeNewswire
-
02 May 2022 07:30:00 By Nasdaq GlobeNewswire
-
15 Mar 2022 15:30:28 By Nasdaq GlobeNewswire
-
09 Mar 2022 07:00:01 By Nasdaq GlobeNewswire
-
28 Feb 2022 15:01:00 By Nasdaq GlobeNewswire
-
10 Feb 2022 07:00:01 By Nasdaq GlobeNewswire
-
Denali Therapeutics Announces Appointment of Erik Harris to Board of Directors
07 Feb 2022 08:00:01 By Nasdaq GlobeNewswire
-
01 Feb 2022 08:00:01 By Nasdaq GlobeNewswire